There is a well-established heterogeneity in BC subtypes with presence, absence or a combination of estrogen receptor alpha (ER ), human epidermal growth factor receptor (HER) and progesterone receptors (PR), that dictate treatment strategies. The gene discussed is ESR1; the disease is breast cancer.